DomoSafety launches a pilot program with Roche

For people living with Spinal Muscular Atrophy (SMA), like many people with chronic conditions, digital health technologies bear the potential to monitor disease progression in real-life, continuously and in a holistic manner, and to provide solutions to support people in living an independent life and feeling safer and freer, at home and on the go

Our portfolio company DomoSafety launches a pilot program with Roche to improve the quality of life of patients with this rare neuromuscular disease.

Read the article…


Guillaume DuPasquier – CEO of DomoSafety